Custom Competitive Intelligence
Addressing strategic considerations including MOA background, clinical development coverage, ongoing trial data and impact.
Current and future treatment paradigms to encompass epidemiology, tumor biology, regulatory strategies, target product profile & relation to existing competitive end points.
Tumor Strategy and Development Planning
Optimized drug development strategy useful to asses clinical and commercial potential, validate life cycle management, provide strategic and clinical insights.
Qualitative Market Research
Key Qualitative Insights which includes in depth, MD moderated interviews with academic and community experts complete with Discussion Guide, Analysis, and medical team insights.
Advisory Boards (Global Congress, Europe and Asia)
Full service capabilities including identification, recruitment, on-site support including travel, content and discussion guide creation.